Tuberculosis (TB), once overtaken by COVID-19 as the world’s leading infectious disease killer, remains a significant global health threat. However, a new study published in Nature Medicine reveals a troubling dimension to the crisis: widespread misdiagnosis. Researchers estimate that approximately 3 million TB cases are incorrectly diagnosed each year, hindering effective treatment and potentially exacerbating the spread of the disease.
The study, analyzing data from 111 low- and middle-income countries in 2023, highlights a critical gap between presumed and actual TB prevalence. The findings suggest that a substantial portion of individuals receiving treatment for TB may not actually have the disease, while a comparable number of infected individuals are going undiagnosed. This widespread inaccuracy in TB diagnosis has significant implications for patient care, public health resources, and global control efforts.
According to the research, over 2 million people are incorrectly told they have tuberculosis annually – receiving what are known as false positive diagnoses. Simultaneously, around 1 million people with active TB are missed, resulting in false negative diagnoses. Which means that as many as one in four individuals treated for TB may not require the lengthy and complex treatment regimen, while a significant number of contagious individuals remain untreated, continuing to pose a risk to their communities. The study estimates that approximately 6.8 million TB notifications were reported in 2023 across the countries analyzed.
The reasons for these high rates of misdiagnosis are complex. Clinicians in resource-limited settings often rely on symptoms and limited diagnostic tools, leading to inaccuracies. “Clinicians may be making the best decision for the patient, but the diagnostics they are using have big deficiencies,” explained Nicolas Menzies, a co-author of the study and an associate professor of global health at the Harvard T.H. Chan School of Public Health, in a report from Harvard University highlighting the research. False positives can lead to unnecessary treatment, with potential side effects and costs, while false negatives allow the disease to progress, and spread.
The Impact of Incorrect Diagnoses
The consequences of misdiagnosis extend beyond individual patient care. False positive diagnoses divert valuable resources from those who genuinely require treatment, straining already overburdened healthcare systems. Individuals incorrectly diagnosed with TB may experience stigma and social isolation. Conversely, false negatives contribute to the continued transmission of the disease, hindering progress towards global elimination goals. Tuberculosis claimed the lives of 1.23 million people in 2024 and sickens about 10 million people each year, according to recent data reported earlier this month.
Improving TB Diagnostics
Researchers suggest that scaling up new polymerase chain reaction (PCR)-based diagnostics could substantially reduce under-diagnosis, but may only have a limited impact on false positive rates. The study emphasizes the need for higher-sensitivity bacteriological tests, combined with a reduced reliance on clinical diagnosis alone. This requires investment in laboratory infrastructure, training of healthcare workers, and improved access to accurate diagnostic tools, particularly in low- and middle-income countries.
The Global TB Community Advisory Board (TB CAB) offers regular updates on tuberculosis research and advocacy. Their latest newsletter, Issue #5 from February 15, 2026, provides further information and resources for those interested in learning more about TB. You can subscribe to the TB CAB Weekly Newsletter here.
Looking ahead, addressing the global TB crisis requires a multifaceted approach. Improved diagnostic accuracy is paramount, but it must be coupled with strengthened healthcare systems, increased funding for research and development, and a commitment to equitable access to care. Continued monitoring of diagnostic performance and ongoing evaluation of new technologies will be crucial to reducing misdiagnosis rates and ultimately controlling this deadly disease.
What are your thoughts on the challenges of TB diagnosis in resource-limited settings? Share your comments below, and help spread awareness about this critical public health issue.
Disclaimer: This article provides informational content and should not be considered medical advice. Please consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
